Given that we did not observe upregulation of Tcf1/7, Myc, and cyclin D1 in BRCA2-null ovarian cancer cells, the potential absence of these prosurvival mechanisms may very well contribute to the improved survival observed in patients with BRCA2 ovarian cancer (15). Here, MYC is linked to ovarian carcinoma.